한글목차

감기약 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 98억 2,000만 달러에서 2026년에는 104억 달러로, CAGR 5.9%로 성장할 것으로 전망됩니다. 지난 몇 년간의 성장 요인으로는 높은 감기 감염률, 일반의약품의 광범위한 가용성, 전통적인 가정 요법의 사용, 소매 약국의 강력한 침투, 계절적 수요 패턴 등을 들 수 있습니다.

감기약 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 130억 6,000만 달러에 달하고, CAGR은 5.9%가 될 전망입니다. 예측 기간의 성장 요인으로는 자가 치료 실천 증가, 도시 인구 밀도 증가, 오염 관련 호흡기질환 증가, E-Commerce 약국 확대, 신속한 증상 완화에 대한 수요 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 자연요법 및 허브 요법에 대한 수요 증가, 다증상 완화 제품의 성장, 시판 감기약 선호도 증가, 재택 증상 관리 확대, 셀프 케어 옵션에 대한 소비자 인식 증가 등을 꼽을 수 있습니다.

호흡기 감염증의 발생률 증가는 향후 몇 년 동안 감기 치료제 시장의 성장을 견인할 것으로 예상됩니다. 호흡기 감염은 부비동, 인후, 기도, 폐 등 호흡기 계통에 영향을 미치는 질환으로 바이러스, 세균, 기타 병원균에 의해 발생합니다. 이러한 감염증의 증가의 주요 요인은 팬데믹 관련 봉쇄 및 사회적 거리두기로 인한 바이러스 노출 감소에 따른 면역력 저하가 주요 원인으로 꼽히고 있습니다. 감기약은 코막힘, 기침, 인후통 등의 증상을 완화하여 호흡기 감염을 관리하고, 면역 체계가 근본적인 감염과 싸우는 동안 증상을 완화하는 데 도움을 줍니다. 예를 들어, 영국 정부 기관인 통계청(ONS)에 따르면, 2023년 3월 영국에서 COVID-19 감염이 증가하여 인구의 약 2.66%(40명 중 1명)가 양성 반응을 보였고, 입원 환자 수는 10만 명당 10.62명에 이르렀다고 합니다. 그 결과, 호흡기 감염증의 발생률 증가가 감기약 시장의 성장을 견인하고 있습니다.

감기약 시장의 주요 기업들은 안전하고 화학제품이 없는 대안에 대한 수요 증가에 대응하기 위해 제품 효과와 소비자 신뢰도를 높이면서 깨끗한 기침 및 감기약과 같은 혁신적인 제품 개발에 주력하고 있습니다. 클린 기침/감기약은 인공색소, 감미료, 방부제, 일반적인 알레르기 유발 물질을 포함하지 않고, 보다 안전한 증상 관리를 위해 천연 또는 유기농 성분에 의존하는 제제입니다. 예를 들어, 2023년 9월, 미국 헬스케어 기업 제네쿠사(Genexa)는 어린이를 위한 새로운 청정 기침-감기약 '키즈 멀티 증상 감기-독감약' 및 '키즈 낮용+밤용 기침약 밸류팩'을 출시하였습니다. 이 제품들은 인공 색소, 감미료, 파라벤, 일반적인 알레르겐을 배제하고 인공 충전제 대신 유기농 아가베 시럽을 천연 대체품으로 사용했습니다. 기존 제품과 동일한 유효 성분을 함유하고 있으면서도 깨끗하고 무독성 처방으로 효과적인 완화를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cold remedies are treatments designed to ease symptoms of the common cold, including congestion, cough, and sore throat. They encompass medications, natural therapies, and supportive care to improve comfort and aid recovery. These remedies assist in managing symptoms but do not eliminate the viral infection.

The primary drug categories for cold treatment include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines are drugs that inhibit histamine receptors to alleviate allergy symptoms, including sneezing, itching, and nasal congestion. They are available in various forms such as oral syrups, tablets and pills, nasal drops, lozenges, and others, and are distributed through multiple channels, including hospital pharmacies, retail pharmacies, drug stores, supermarkets and hypermarkets, as well as e-commerce and online pharmacies.

Tariffs have affected the cold remedies market by increasing the cost of imported active ingredients, herbal extracts, and packaging materials used in symptomatic treatments. These impacts have been most pronounced in combination remedy and herbal product segments, particularly in north america and europe where ingredient sourcing is globally diversified. Asia-pacific manufacturers have faced supply disruptions due to import dependencies. However, tariffs have encouraged domestic production of OTC remedies and local sourcing of natural ingredients.

The cold remedies market research report is one of a series of new reports from The Business Research Company that provides cold remedies market statistics, including cold remedies industry global market size, regional shares, competitors with a cold remedies market share, detailed cold remedies market segments, market trends and opportunities, and any further data you may need to thrive in the cold remedies industry. This cold remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cold remedies market size has grown strongly in recent years. It will grow from $9.82 billion in 2025 to $10.4 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to high prevalence of common cold infections, widespread availability of OTC remedies, traditional use of home treatments, strong retail pharmacy penetration, seasonal demand patterns.

The cold remedies market size is expected to see strong growth in the next few years. It will grow to $13.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to growth in self-medication practices, increasing urban population density, rising pollution-related respiratory issues, expansion of e-commerce pharmacies, demand for fast symptom relief. Major trends in the forecast period include rising demand for natural and herbal remedies, growth in multi-symptom relief products, increased preference for OTC cold treatments, expansion of home-based symptom management, growing consumer awareness of self-care options.

The increasing incidence of respiratory infections is expected to drive the growth of the cold remedies market in the coming years. Respiratory infections are illnesses that affect the respiratory system, including the sinuses, throat, airways, and lungs, and are caused by viruses, bacteria, or other pathogens. These infections are on the rise mainly due to weakened immunity resulting from reduced exposure to viruses during pandemic-related lockdowns and social distancing measures. Cold remedies assist in managing respiratory infections by easing symptoms such as congestion, cough, and sore throat, offering relief while the immune system combats the underlying infection. For example, in March 2023, according to the Office for National Statistics, a UK-based government agency, COVID-19 infections in England increased, with approximately 2.66% of the population testing positive (1 in 40 people), and hospital admissions rose to 10.62 per 100,000 individuals. Consequently, the rising incidence of respiratory infections is fueling the growth of the cold remedies market.

Major companies in the cold remedies market are concentrating on creating innovative products, such as clean cough and cold medicines, to address the rising demand for safer, chemical-free options while improving product efficacy and consumer confidence. Clean cough and cold medicines are formulations free from artificial dyes, sweeteners, preservatives, and common allergens, relying on natural or organic ingredients for safer symptom management. For example, in September 2023, Genexa Inc., a US-based healthcare firm, introduced new clean cough and cold medicines for children, including Kids' Multi-Symptom Cold And Flu and Kids' Daytime + Nighttime Cough Relief Value Pack. These products exclude artificial dyes, sweeteners, parabens, and common allergens, using organic agave syrup as a natural substitute for artificial fillers. They deliver effective relief with the same active ingredients as conventional brands but in a clean, non-toxic formulation.

In February 2024, Cipla Limited, an India-based pharmaceutical company, acquired Actor Pharma for $48.6 million. Through this acquisition, Cipla intends to strengthen its over-the-counter (OTC) portfolio by broadening its range of consumer healthcare products, increasing its market presence, and reinforcing its position in the self-care and wellness segment. Actor Pharma (Pty) Limited is a South Africa-based company focused on manufacturing expectorants.

Major companies operating in the cold remedies market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Haleon plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Prestige Brands Holdings Inc., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Centurion Remedies Private Limited, Himalaya Wellness Company, Genexa Inc., Fibovil Pharmaceuticals Pvt. Ltd.

North America was the largest region in the cold remedies market in 2025. The regions covered in the cold remedies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cold remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold remedies market consists of sales of inhalers, topical rubs, throat sprays, homeopathic remedies, and vitamin supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold Remedies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cold remedies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cold remedies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cold remedies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Other Drugs
• 2) By Dosage Type: Oral Syrups; Tablets And Pills; Nasal Drops; Lozenges; Other Dosage Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Supermarkets And Hypermarkets; E-Commerce And Online Pharmacies
• Subsegments:
• 1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines; Combination Antihistamines
• 2) By Expectorants: Guaifenesin-Based Expectorants; Herbal Expectorants; Combination Expectorants
• 3) By Bronchodilators: Beta-Agonists; Anticholinergics; Methylxanthines
• 4) By Decongestants: Oral Decongestants; Nasal Spray Decongestants; Combination Decongestants
• 5) By Other Drugs: Pain Relievers; Cough Suppressants; Herbal And Homeopathic Remedies
• Companies Mentioned: Pfizer Inc.; The Procter & Gamble Company; Johnson & Johnson; Bayer AG; Sanofi S.A.; AstraZeneca plc; Novartis AG; GlaxoSmithKline plc; Reckitt Benckiser Group plc; Teva Pharmaceutical Industries Ltd.; Haleon plc; Sun Pharmaceutical Industries Ltd.; Perrigo Company plc; Prestige Brands Holdings Inc.; Weefsel Pharma Pvt. Ltd.; Sunwin Healthcare Pvt. Ltd.; AdvaCare Pharma USA; Centurion Remedies Private Limited; Himalaya Wellness Company; Genexa Inc.; Fibovil Pharmaceuticals Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cold Remedies Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cold Remedies Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cold Remedies Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cold Remedies Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Sustainability, Climate Tech & Circular Economy
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Natural And Herbal Remedies
  • 4.2.2 Growth In Multi-Symptom Relief Products
  • 4.2.3 Increased Preference For Otc Cold Treatments
  • 4.2.4 Expansion Of Home-Based Symptom Management
  • 4.2.5 Growing Consumer Awareness Of Self-Care Options

5. Cold Remedies Market Analysis Of End Use Industries

• 5.1 Retail Pharmacies
• 5.2 Drug Stores
• 5.3 Supermarkets And Hypermarkets
• 5.4 Hospitals
• 5.5 Online Pharmacies

6. Cold Remedies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cold Remedies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cold Remedies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cold Remedies Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cold Remedies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cold Remedies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cold Remedies Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cold Remedies Market Segmentation

• 9.1. Global Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antihistamines, Expectorants, Bronchodilators, Decongestants, Other Drugs
• 9.2. Global Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Syrups, Tablets And Pills, Nasal Drops, Lozenges, Other Dosage Types
• 9.3. Global Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Drug Stores, Supermarkets And Hypermarkets, E-Commerce And Online Pharmacies
• 9.4. Global Cold Remedies Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• First-Generation Antihistamines, Second-Generation Antihistamines, Combination Antihistamines
• 9.5. Global Cold Remedies Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Guaifenesin-Based Expectorants, Herbal Expectorants, Combination Expectorants
• 9.6. Global Cold Remedies Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Beta-Agonists, Anticholinergics, Methylxanthines
• 9.7. Global Cold Remedies Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Decongestants, Nasal Spray Decongestants, Combination Decongestants
• 9.8. Global Cold Remedies Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pain Relievers, Cough Suppressants, Herbal And Homeopathic Remedies

10. Cold Remedies Market Regional And Country Analysis

• 10.1. Global Cold Remedies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cold Remedies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cold Remedies Market

• 11.1. Asia-Pacific Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cold Remedies Market

• 12.1. China Cold Remedies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cold Remedies Market

• 13.1. India Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cold Remedies Market

• 14.1. Japan Cold Remedies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cold Remedies Market

• 15.1. Australia Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cold Remedies Market

• 16.1. Indonesia Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cold Remedies Market

• 17.1. South Korea Cold Remedies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cold Remedies Market

• 18.1. Taiwan Cold Remedies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cold Remedies Market

• 19.1. South East Asia Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cold Remedies Market

• 20.1. Western Europe Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cold Remedies Market

• 21.1. UK Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cold Remedies Market

• 22.1. Germany Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cold Remedies Market

• 23.1. France Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cold Remedies Market

• 24.1. Italy Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cold Remedies Market

• 25.1. Spain Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cold Remedies Market

• 26.1. Eastern Europe Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cold Remedies Market

• 27.1. Russia Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cold Remedies Market

• 28.1. North America Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cold Remedies Market

• 29.1. USA Cold Remedies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cold Remedies Market

• 30.1. Canada Cold Remedies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cold Remedies Market

• 31.1. South America Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cold Remedies Market

• 32.1. Brazil Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cold Remedies Market

• 33.1. Middle East Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cold Remedies Market

• 34.1. Africa Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cold Remedies Market, Segmentation By Drug Type, Segmentation By Dosage Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cold Remedies Market Regulatory and Investment Landscape

36. Cold Remedies Market Competitive Landscape And Company Profiles

• 36.1. Cold Remedies Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cold Remedies Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cold Remedies Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Cold Remedies Market Other Major And Innovative Companies

• AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Haleon plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Prestige Brands Holdings Inc., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Centurion Remedies Private Limited, Himalaya Wellness Company, Genexa Inc.

38. Global Cold Remedies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cold Remedies Market

40. Cold Remedies Market High Potential Countries, Segments and Strategies

• 40.1 Cold Remedies Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cold Remedies Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cold Remedies Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer